Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 4th February 2020
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Equine inhaler receives marketing authorisation
"Treating severe equine asthma can be challenging for veterinarians and horse owners" - Erich Schoett.

Aservo Equihaler® will be available for EU distribution in 2020

A novel equine inhaler set to benefit horses suffering from severe equine asthma has been granted marketing approval by the European Commission.


Marking an industry-first in equine medicine, the Aservo Equihaler® is the culmination of more than a decade of collaboration between Boehringer Ingelheim’s human pharma and animal health R&D groups. It is expected to be available for veterinary surgeons in the EU in 2020.


The inhaler incorporates a unique Soft Mist Technology®, found in the human Respimat® inhaler. This allows the active ingredient - ciclesonide - to be inhaled deep into the lung, thereby reducing the risk of lower airway inflammation.

Designed specifically for horses, the inhaler also features an ergonomic handle, dosing lever for ease of handling and a nostril adaptor that fits inside the nostril of the horse to allow for easy inhalation.

Erich Schoett, global business head of equine for the Boehringer Ingelheim Animal Health Business Unit, said: “Treating severe equine asthma can be challenging for veterinarians and horse owners, who struggle to find safe and effective ways to help horses breathe.


“Bringing a new, safe and effective treatment to the market is something that we can really be proud of. It is a strong indicator of the commitment that Boehringer Ingelheim has to the health and welfare of horses, and to the investment that we make into continuing to advance therapies through collaboration and innovation.”

Become a member or log in to add this story to your CPD history

Reporting service for dead wild birds updated

News Story 1
 The Animal and Plant Health Agency (APHA) has updated its online reporting service for dead wild birds.

The new version allows those reporting a dead bird to drop a pin on a map when reporting the location. It also includes a wider range of wild bird species groups to select from when describing the bird.

The online service, which helps APHA to monitor the spread of diseases such as avian influenza, can be accessed here. 

Click here for more...
News Shorts
NI chief vet urges bluetongue vigilance

Northern Ireland's chief veterinary officer (CVO) has urged farmers to be vigilant for signs of bluetongue, after the Animal and Plant Health Agency warned there was a very high probability of further cases in Great Britain.

There have been 126 confirmed cases of bluetongue virus serotype 3 in England since November 2023, with no cases reported in Northern Ireland. The movement of live ruminants from Great Britain to Northern Ireland is currently suspended.

According to the Department of Agriculture, Environment and Rural Affairs (DAERA), the virus is most likely to enter Northern Ireland through infected animals or germplasm (semen or ova) being imported.

Brian Dooher, Northern Ireland's CVO, said: "Surveillance for this disease within Northern Ireland has been increased to assist with detection at the earliest opportunity which will facilitate more effective control measures."

Farmers should report any suspicions of the disease to their private veterinary practitioner, the DAERA Helpline on 0300 200 7840 or their local DAERA Direct Veterinary Office.